Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML

Clinical trial NCT05413915 · TERMINATED

Trial details

NCT number: NCT05413915
Sponsor: Sarit Assouline
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia Chronic Myeloid Leukemia, BCR/ABL-Positive Chronic Myeloid Leukemia in Remission

Start date: 2023-11-01
Primary completion: 2025-07-02
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.